Skip to main content
. 2022 Sep 17;44(9):4303–4313. doi: 10.3390/cimb44090296

Figure 3.

Figure 3

Expression levels of tissue remodeling proteins and inflammatory molecules increased in the FDM and control eyes: (a) immunohistochemical analysis of MMP2, NF-κB, and COL-I expression at day 7 in the FDM and control groups in the retina; (b) gene staining intensity of MMP2, NF-κB, and COL-I in the retina determined using Image J software.; (c) immunohistochemical analysis of MMP2, NF-κB, and COL-I expression at day 7 in the FDM and control groups in the sclera; (d) gene staining intensity of MMP2, NF-κB, and COL-I in sclera determined using Image J software. * p < 0.05 (paired t-tests).